Results 61 to 70 of about 23,909 (233)
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ9-tetrahydrocannabinol: a pilot study [PDF]
, 2021 Erica N. Peters +9 more
openalex +1 more source
Ultra‐refractory epilepsy: The newly described entity
Epilepsia Open, EarlyView.Abstract Objective Drug‐resistant epilepsy (DRE) is defined as the failure of two antiseizure medications (ASMs) to achieve complete seizure control, affecting approximately 30% of epilepsy patients. In some cases, additional ASMs and surgical approaches are also unsuccessful.
Jan Vinklárek +13 more
wiley +1 more source
Epilepsia Open, EarlyView.Abstract Objective Dravet syndrome (DS) is a rare disease with a high clinical and socioeconomic impact on patients, society, and the healthcare system. The recent approval of therapies such as fenfluramine (FFA) has transformed the treatment landscape; however, data on their cost‐effectiveness are still scarce. This study evaluates the real‐world cost‐
Paolo A. Cortesi +15 more
wiley +1 more source
Wirksamkeit von Cannabidiol: Klinische Studien mit Cannabidiol und Cannabidiol-haltigen Extrakten [PDF]
Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine, 2017 <b><i>Hintergrund:</i></b> Tetrahydrocannabinol (THC) und Cannabidiol (CBD) sind die prominentesten Wirkstoffe aus der weiblichen Hanfpflanze (<i>Cannabis sativa</i> L.). Während sich die Kombination von THC- und CBD-reichen Extrakten dank ihrer analgetischen und antispastischen Wirkungen bei Patienten mit Multipler ...
openaire +1 more source
Noninvasive Disease Diagnostics: The Swiss Contribution Highlights to Breath Analysis Research
Helvetica Chimica Acta, EarlyView.Breath analysis networks across Switzerland linking health monitoring, clinical applications, population studies, and data‐driven public health decisions. ABSTRACT To celebrate the 125th anniversary of the Swiss Chemical Society, we present a review and perspective to highlight the recent research in breath analysis that has been conducted in ...
Stefan James Swift +6 more
wiley +1 more source
Research progress on the role of inflammatory mediators in the pathogenesis of epilepsy
Ibrain, Volume 11, Issue 1, Page 44-58, Spring 2025.In the central nervous system, activated immune cells lead to the overproduction of inflammatory mediators through the corresponding signal pathway. Under the stimulation of inflammatory factors, neuroinflammation ultimately occurs. Overexpression of inflammatory mediators and activated immunocytes plays an important role in the emergence and ...
Yue Yu, Fei‐Ji Sun
wiley +1 more source
Ibrain, EarlyView.Chemotherapy‐induced peripheral neuropathy (CIPN) remains a major clinical challenge, with central sensitization considered an important pathological mechanism in its occurrence and persistence. This review focuses on spinal astrocytes and microglia, systematically summarizing the pathological mechanisms of spinal glial cells involved in CIPN caused by
Long Gu, Song Cao, Yonghuai Feng
wiley +1 more source
Cannabidiol in autism: Clinical pharmacology priorities for trial design [PDF]
British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 357-359, February 2026.
Gislei Frota Aragão +2 more
openalex +2 more sources
Pharmacokinetic Interaction of Kratom and Cannabidiol in Male Rats
PharmaceuticsKratom and cannabidiol products are used to self-treat a variety of conditions, including anxiety and pain, and to elevate mood. Research into the individual pharmacokinetic properties of commercially available kratom and cannabidiol products has been ...
Erin C. Berthold +8 more
doaj +1 more source